[Mutations in TET2 in myeloid cancers].
Bernard
Olivier A
OA
E0210 Inserm, Tour Pasteur, Hôpital Necker, 149, rue de Sèvres, 75743 Paris Cedex 15, France. olivier.bernard@inserm.fr
Delhommeau
François
F
Fontenay
Michaela
M
Vainchenker
William
W
D050676:Core Binding Factor Alpha 2 Subunit / Q000235:genetics; D004268:DNA-Binding Proteins / Q000235:genetics*; D049308:Dioxygenases; D006410:Hematopoiesis; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000235:genetics; D009196:Myeloproliferative Disorders / Q000235:genetics; D011518:Proto-Oncogene Proteins / Q000235:genetics*
D050676:Core Binding Factor Alpha 2 Subunit; D004268:DNA-Binding Proteins; D011518:Proto-Oncogene Proteins; C493728:RUNX1 protein, human; D049308:Dioxygenases; C541081:TET2 protein, human